RecruitingPhase 3NCT03965988
Docosahexaenoic Acid on Breath Holding Spells in Children
Effect of Docosahexaenoic Acid on Breath Holding Spells in Children: A Randomized Controlled Trial
Sponsor
Sherief Abd-Elsalam
Enrollment
60 participants
Start Date
May 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
DHA on Breath Holding Spells
Eligibility
Min Age: 1 MonthMax Age: 5 Years
Inclusion Criteria1
- Children with newly diagnosed sprlls
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDHA
Docosahexaenoic acid
DRUGPlacebo
Placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03965988